---
title: "Penumbra, Inc. (PEN.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PEN.US.md"
symbol: "PEN.US"
name: "Penumbra, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-20T10:48:15.120Z"
locales:
  - [en](https://longbridge.com/en/quote/PEN.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PEN.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PEN.US.md)
---

# Penumbra, Inc. (PEN.US)

## Company Overview

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.penumbrainc.com](https://www.penumbrainc.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: B (0.22)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 13 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 17.27% |  |
| Net Profit YoY | 305.01% |  |
| P/B Ratio | 8.71 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 12843676833.75 |  |
| Revenue | 1454283000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 12.73% | B |
| Profit Margin | 11.76% | B |
| Gross Margin | 67.62% | A |
| Revenue YoY | 17.27% | B |
| Net Profit YoY | 305.01% | A |
| Total Assets YoY | 19.15% | A |
| Net Assets YoY | 21.51% | A |
| Cash Flow Margin | 161.75% | B |
| OCF YoY | 17.27% | B |
| Turnover | 0.83 | B |
| Gearing Ratio | 22.37% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Penumbra, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "17.27%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "305.01%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "8.71",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "12843676833.75",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1454283000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "12.73%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "11.76%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "67.62%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "17.27%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "305.01%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "19.15%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "21.51%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "161.75%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "17.27%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.83",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "22.37%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 75.09 | 42/183 | 85.72 | 74.09 | 67.31 |
| PB | 8.71 | 120/183 | 9.21 | 8.49 | 7.65 |
| PS (TTM) | 8.83 | 109/183 | 9.37 | 8.47 | 7.73 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-12T04:00:00.000Z

Total Analysts: **18**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 2 | 11% |
| Overweight | 2 | 11% |
| Hold | 13 | 72% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 326.55 |
| Highest Target | 374.00 |
| Lowest Target | 326.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/PEN.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/PEN.US/norm.md)
- [Related News](https://longbridge.com/en/quote/PEN.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/PEN.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**